Medication Utilization and Annual Health Care Costs in Patients With Type 2 Diabetes Mellitus Before and After Bariatric Surgery

Authors:
  • JCJeanne M. Clark
    Jeanne M. Clark
  • ASAndrew D. Shore
    Andrew D. Shore
  • TMThomas H. Magnuson
    Thomas H. Magnuson
  • TRThomas Richards
    Thomas Richards
  • FDFrancesca Dominici
    Francesca Dominici
  • JWJonathan P. Weiner
    Jonathan P. Weiner
  • AWAlbert W. Wu
    Albert W. Wu
  • JSJodi B. Segal
    Jodi B. Segal

Abstract
The rapidly growing epidemics of obesity and diabetes threaten to overburden the world's health care systems.1,2 From an epidemiological standpoint, once these diseases develop they are rarely reversed. Dietary, pharmaceutical, and behavior treatments for obesity are associated with high failure rates, and medical management of diabetes is also often unsuccessful.3,4 Despite many efforts to improve the control of glucose levels in diabetes, including clinical guidelines and patient and provider education, less than half of all patients with type 2 diabetes mellitus achieve the American Diabetes Association recommendation of a hemoglobin A1c level of less than 7%.5

This publication has 20 references indexed in Scilit: